| Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612) |
|---|
| 07/13/2005 | EP1551799A1 Cyclohexyl sulphones as gamma-secretase inhibitors |
| 07/13/2005 | EP1551797A1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 07/13/2005 | CN1636597A Compounds for the treatment of female sexual dysfunction |
| 07/13/2005 | CN1210268C (Cyclo) alkyl substituted-gamma-aminobutyric acid derivatives (=GABA analogurs), their preparation and their use in the treatment of neurolog disorders |
| 07/13/2005 | CN1210263C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 07/12/2005 | US6916848 Compounds for the treatment of metabolic disorders |
| 07/12/2005 | US6916797 α-arylethylpiperazine derivatives as neurokinin antagonists |
| 07/12/2005 | US6916461 Metal complexes that contain perfluoroalkyl, process for their production and their use in NMR diagnosis |
| 07/12/2005 | CA2128378C Novel acaricidally active tetrazine derivatives |
| 07/07/2005 | US20050148566 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same |
| 07/07/2005 | US20050147563 Imaging lymph nodes with a Gadolinium complex of 10-[2-hydroxy-4-aza-5-oxo-7-aza-7-(perfluorooctylsulfonyl)-nonyl]-1,4,7-tris (carboxymethyl)-1,4,7,10-tetraazacyclododecane; in vivo contrast media in nuclear spin tomography; blood-pool agents, lymphographic agents |
| 07/06/2005 | CN1209362C Tetrazolyl-phenyl acetamide glucokinase activators |
| 06/30/2005 | WO2005058884A2 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005058808A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005020899A3 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity |
| 06/30/2005 | CA2549660A1 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | CA2549598A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 06/29/2005 | EP1546122A1 Process for the manufacture of valsartan |
| 06/29/2005 | EP1545513A2 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 06/29/2005 | EP1545498A2 Backbone-substituted bifunctional dota ligands, complexes and compositions thereof, and methods of using same |
| 06/29/2005 | EP1480635A4 Macrocyclic module compositions |
| 06/29/2005 | CN1208327C Process for preparing S, Síõ-carbonyl disulfhydryl substituted five-membered heterocyclic compound |
| 06/28/2005 | US6911457 Diabetes imaging probes |
| 06/28/2005 | US6911439 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents |
| 06/28/2005 | US6911416 Substituted N-benzoyl-n′(tetrazolylphenyl)-ureas and their use as pest control agents |
| 06/23/2005 | WO2005056508A1 Method for the production of tetrahydrogeranylacetone |
| 06/23/2005 | WO2005040121A3 Amides that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 06/23/2005 | CA2548262A1 Method for the production of tetrahydrogeranylacetone |
| 06/22/2005 | EP1542980A1 5-aryltetrazole compounds, compositions thereof, and uses therefor |
| 06/22/2005 | EP1082127B1 Succinamide inhibitors of interleukin-1beta converting enzyme |
| 06/22/2005 | CN1630633A N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
| 06/21/2005 | US6908938 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 06/21/2005 | CA2247265C Process for preparing 1,4,7,10-tetraazacyclododecane and its derivatives |
| 06/16/2005 | US20050131038 Process for the preparation of valsartan and intermediates thereof |
| 06/16/2005 | US20050130949 Antiproliferative agents; ATP-ase activity; e.g. 5,9,14-Trimethyl-4-undecyl-1,5,9,14-tetraazacycloheptadecan-2-one; budmunchiamine compounds |
| 06/16/2005 | US20050130941 Methods of treating alzheimer's disease |
| 06/15/2005 | EP1539691A2 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 06/15/2005 | EP1311504B1 Tetrazolyl-phenyl acetamide glucokinase activators |
| 06/15/2005 | CN1628106A Salts of valsartan |
| 06/14/2005 | US6905804 Charge transport material comprising a fluorenone hydrazone having a) least two fluorenone alkylsulfonylphenylhydrazone groups, b) at least two fluorenone pyrrolylhydrazone groups, c) at least two fluorenone benzotriazolylhydrazone groups, d) |
| 06/14/2005 | CA2304967C 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 06/09/2005 | WO2005051930A1 Modified-protein formation inhibitor |
| 06/09/2005 | WO2005051929A1 Conversion of aromatic nitriles into tetrazoles |
| 06/09/2005 | WO2005051928A1 Process for production of tetrazolyl compounds |
| 06/09/2005 | WO2005051893A2 Vitamin d receptor modulators |
| 06/09/2005 | WO2005021535A3 A method of removing the triphenylmethane protecting group |
| 06/09/2005 | US20050124671 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 06/09/2005 | US20050123849 Electrophotographic organophotoreceptors with novel charge transport materials |
| 06/08/2005 | EP1537077A2 4-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties |
| 06/08/2005 | EP1537075A2 Diarylurea derivatives and their use as chloride channel blockers |
| 06/08/2005 | EP1536784A1 Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 06/08/2005 | EP1465854A4 Chalcone derivatives and their use to treat diseases |
| 06/08/2005 | EP1220831B1 Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 06/07/2005 | US6903218 Substituted or unsubstituted aryl-1-hydroxyethylaminocarbonylalkyl-chroman-sulfonamide compounds are useful in the treatment of beta-3 receptor mediated conditions |
| 06/07/2005 | US6903088 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/02/2005 | WO2005049588A1 Process for isolation of valsartan |
| 06/02/2005 | WO2005049587A1 Process for preparation of biphenyl tetrazole |
| 06/02/2005 | WO2005049586A1 Process for production of (s) -n-pentanoyl-n-[[2’-(1h-tetrazole-5yl) [1,1’-biphenyl]-4-yl]methyl]-l-valine |
| 06/02/2005 | WO2005048810A2 Sigma-2 receptor radiotracers for imaging the proliferative status of solid tumors |
| 06/02/2005 | US20050119488 Phenyltetrazole compounds |
| 06/01/2005 | EP1535914A1 Processes for producing epoxytriazole derivative and intermediate therefor |
| 06/01/2005 | EP1115695B1 (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity |
| 06/01/2005 | EP0991625B1 Inhibitors of factor xa with a neutral p1 specificity group |
| 06/01/2005 | CN1203899C Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy |
| 06/01/2005 | CN1203898C Perfluoroalkyl-containing metal complexes, its preparing method and use in NMR diagnostics |
| 05/31/2005 | US6900207 N-containing five-membered ring compounds and pharmaceutical agents comprising the same as active ingredient |
| 05/31/2005 | CA2324343C C11 oxymyl and hydroxylamino prostaglandins useful as medicaments |
| 05/26/2005 | WO2005047236A1 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 05/26/2005 | US20050113580 2-(3-{3-[[2-chloro-3-(trifluoromethyl)benzyl](2,2-dephenylethyl)amino]propoxy}phenyl)-ethanol; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption |
| 05/26/2005 | CA2534342A1 Amino acid prodrugs |
| 05/25/2005 | EP1533305A1 A process for the preparation of valsartan and intermediates thereof |
| 05/25/2005 | EP1533292A1 Dibenzylamine compound and medicinal use thereof |
| 05/25/2005 | EP1531879A1 Use of organic compounds |
| 05/25/2005 | EP1531822A1 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders |
| 05/25/2005 | CN1203047C Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 05/24/2005 | US6897237 MMP-12 inhibitors |
| 05/19/2005 | US20050107421 Nitrogen compounds such as 2-Butyl-1-(2-methylpropyl)-1H-tetrazolo[1,5-a]imidazo[4,5-c][1,8]naphthyridine, used to induce biosynthesis of cytokines such as interferons and tumor necrosis factors, or for prophylaxis of viral diseases |
| 05/19/2005 | US20050107398 benzamide compounds labeled with detectable radionuclides that selectively bind to cancer cells, used for medical diagnosis such as tomography |
| 05/19/2005 | US20050107345 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 05/19/2005 | DE10348023A1 Neue Alanyl-Aminopeptidasen-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen New alanyl aminopeptidase inhibitors for functional interference of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases |
| 05/18/2005 | CN1617852A Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 05/18/2005 | CN1617850A Dibenzylamine compound and medicinal use thereof |
| 05/18/2005 | CN1616453A Antivirally active heterocyclic azahexane derivatives |
| 05/17/2005 | US6894165 Imidazonaphthyridines |
| 05/17/2005 | US6894151 Lithium complexes of N-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane, their production and use |
| 05/17/2005 | US6893650 Fungicides; locus infestation; such as N,N-dimethyl-N'-(4-(3-trifluoromethylbenzylthio)-2,5-xylyl)formamidine |
| 05/12/2005 | WO2005041867A2 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3’(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrozol-3-one choline |
| 05/12/2005 | US20050101652 New salt hydrates |
| 05/12/2005 | CA2543216A1 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrozol-3-one choline |
| 05/11/2005 | EP1528921A2 Methods for treatment and prevention of gastrointestinal conditions |
| 05/11/2005 | CN1200933C Substituted N-benzoyl-N'-(tetrazolylphenyl)-ureas and their use as pest control agents |
| 05/11/2005 | CN1200704C Appliance of probucol monoesters for treatment of cardiovascular and inflammatory disease |
| 05/10/2005 | US6890956 Cyclohexyl sulphones as gamma-secretase inhibitors |
| 05/06/2005 | WO2005040121A2 Amides that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 05/06/2005 | CA2539967A1 Amides that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 05/04/2005 | EP1528055A2 Sulphonamide Derivatives |
| 05/04/2005 | EP1526851A2 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy |
| 05/04/2005 | CN1612866A Amorphous and crystalline forms of losartan potassium and process for their preparation |
| 05/03/2005 | US6887877 Viricide for hepatitis virus |
| 05/03/2005 | CA2149886C Process for preparing tetrazolyl-benzopyranones |